Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Lung Cancer

  Free Subscription


Articles published in Mol Carcinog

Retrieve available abstracts of 21 articles:
HTML format
Text format



Single Articles


    May 2017
  1. ZHU X, Li D, Zhang Z, Zhu W, et al
    Persistent phosphorylation at specific H3 serine residues involved in chemical carcinogen-induced cell transformation.
    Mol Carcinog. 2017;56:1449-1460.
    PubMed     Text format     Abstract available


    April 2017
  2. ERDEM JS, Arnoldussen YJ, Skaug V, Haugen A, et al
    Copy number variation, increased gene expression and molecular mechanisms of Neurofascin in lung cancer.
    Mol Carcinog. 2017 Apr 18. doi: 10.1002/mc.22664.
    PubMed     Text format     Abstract available


  3. ZHOU C, Chen T, Xie Z, Qin Y, et al
    RACK1 Forms a Complex with FGFR1 and PKM2 and Stimulates the Growth and Migration of Squamous Lung Cancer Cells.
    Mol Carcinog. 2017 Apr 18. doi: 10.1002/mc.22663.
    PubMed     Text format     Abstract available


  4. XIE M, Wu X, Zhang J, Zhang J, et al
    Ski regulates Smads and TAZ signaling to suppress lung cancer progression.
    Mol Carcinog. 2017 Apr 11. doi: 10.1002/mc.22661.
    PubMed     Text format     Abstract available


  5. ZHANG X, Zhou H, Cai L, Fan C, et al
    Kctd20 promotes the development of non-small cell lung cancer through activating Fak/AKT pathway and predicts poor overall survival of patients.
    Mol Carcinog. 2017 Apr 11. doi: 10.1002/mc.22660.
    PubMed     Text format     Abstract available


    March 2017
  6. CHAE DK, Ban E, Yoo YS, Kim EE, et al
    MIR-27a regulates the TGF-beta signaling pathway by targeting SMAD2 and SMAD4 in lung cancer.
    Mol Carcinog. 2017 Mar 31. doi: 10.1002/mc.22655.
    PubMed     Text format     Abstract available


    February 2017
  7. FENG C, Xia Y, Zou P, Shen M, et al
    Curcumin analogue L48H37 induces apoptosis through ROS-mediated endoplasmic reticulum stress and STAT3 pathways in human lung cancer cells.
    Mol Carcinog. 2017 Feb 20. doi: 10.1002/mc.22633.
    PubMed     Text format     Abstract available


  8. YIN J, Liu H, Liu Z, Owzar K, et al
    Pathway-analysis of published genome-wide association studies of lung cancer: A potential role for the CYP4F3 locus.
    Mol Carcinog. 2017 Feb 2. doi: 10.1002/mc.22622.
    PubMed     Text format     Abstract available


    December 2016
  9. MAN S, Li J, Qiu P, Liu J, et al
    Inhibition of lung cancer in diethylnitrosamine-induced mice by Rhizoma paridis saponins.
    Mol Carcinog. 2016 Dec 19. doi: 10.1002/mc.22601.
    PubMed     Text format     Abstract available


    November 2016
  10. ZHOU F, Wang Y, Liu H, Ready N, et al
    Susceptibility loci of CNOT6 in the general mRNA degradation pathway and lung cancer risk - a re-analysis of eight GWASs.
    Mol Carcinog. 2016 Nov 2. doi: 10.1002/mc.22585.
    PubMed     Text format     Abstract available


    September 2016
  11. LI J, Lu J, He Y, Wu Y, et al
    A new functional IDH2 genetic variant is associated with the risk of lung cancer.
    Mol Carcinog. 2016 Sep 20. doi: 10.1002/mc.22573.
    PubMed     Text format     Abstract available


  12. BASSI DE, Zhang J, Renner C, Klein-Szanto AJ, et al
    Targeting proprotein convertases in furin-rich lung cancer cells results in decreased in vitro and in vivo growth.
    Mol Carcinog. 2016 Sep 1. doi: 10.1002/mc.22550.
    PubMed     Text format     Abstract available


    August 2016
  13. ZHANG M, Zeng J, Zhao Z, Liu Z, et al
    Loss of MiR-424-3p, not miR-424-5p, confers chemoresistance through targeting YAP1 in non-small cell lung cancer.
    Mol Carcinog. 2016 Aug 8. doi: 10.1002/mc.22536.
    PubMed     Text format     Abstract available


    May 2016
  14. GAO W, Jin J, Yin J, Land S, et al
    KRAS and TP53 mutations in bronchoscopy samples from former lung cancer patients.
    Mol Carcinog. 2016 May 16. doi: 10.1002/mc.22501.
    PubMed     Text format     Abstract available


    January 2016
  15. SHI L, Zhang B, Sun X, Zhang X, et al
    CC chemokine ligand 18(CCL18) promotes migration and invasion of lung cancer cells by binding to Nir1 through Nir1-ELMO1/DOC180 signaling pathway.
    Mol Carcinog. 2016 Jan 12. doi: 10.1002/mc.22450.
    PubMed     Text format     Abstract available


  16. WEI L, Yao Y, Zhao K, Huang Y, et al
    Oroxylin A inhibits invasion and migration through suppressing ERK/GSK-3beta signaling in snail-expressing non-small-cell lung cancer cells.
    Mol Carcinog. 2016 Jan 6. doi: 10.1002/mc.22456.
    PubMed     Text format     Abstract available


  17. RAVI J, Elbaz M, Wani NA, Nasser MW, et al
    Cannabinoid receptor-2 agonist inhibits macrophage induced EMT in non-small cell lung cancer by downregulation of EGFR pathway.
    Mol Carcinog. 2016 Jan 6. doi: 10.1002/mc.22451.
    PubMed     Text format     Abstract available


    December 2015
  18. SU J, Wu S, Wu H, Li L, et al
    CD44 is functionally crucial for driving lung cancer stem cells metastasis through Wnt/beta-catenin-FoxM1-Twist signaling.
    Mol Carcinog. 2015 Dec 1. doi: 10.1002/mc.22443.
    PubMed     Text format     Abstract available


  19. OJI Y, Tatsumi N, Kobayashi J, Fukuda M, et al
    Wilms' tumor gene WT1 promotes homologous recombination-mediated DNA damage repair.
    Mol Carcinog. 2015;54:1758-71.
    PubMed     Text format     Abstract available


  20. CHOWDHURY SR, Sengupta S, Biswas S, Sen R, et al
    Low fucose containing bacterial polysaccharide facilitate mitochondria-dependent ROS-induced apoptosis of human lung epithelial carcinoma via controlled regulation of MAPKs-mediated Nrf2/Keap1 homeostasis signaling.
    Mol Carcinog. 2015;54:1636-55.
    PubMed     Text format     Abstract available


    November 2015
  21. YU SL, Lee DC, Sohn HA, Lee SY, et al
    Homeobox A9 directly targeted by miR-196b regulates aggressiveness through nuclear Factor-kappa B activity in non-small cell lung cancer cells.
    Mol Carcinog. 2015 Nov 20. doi: 10.1002/mc.22439.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: